Journal Report

ADVANCES IN THERAPY

Download PDF
Journal Information
Journal Title
ADVANCES IN THERAPY
Publisher
SPRINGER
ISSN
0741-238X
E-ISSN
1865-8652
Database
Clarivate
Domain
Health Sciences, Life Sciences, Social Sciences
Classification History
Year A+ A B C
2026 ✓ ✓
2025 ✓ ✓
2024 ✓ ✓
2023 ✓ ✓
2021/2022 ✓ ✓
2020 ✓ ✓
2019 ✓ ✓
2018 ✓
A journal may have more than one classification in the same year. All recorded classifications are displayed.
Recent Articles
Real-World Impact of Maralixibat Treatment on Concomitant Medication Use in USA-Based Patients with Alagille Syndrome and Cholestatic Pruritus: A Retrospective Analysis
Jolan Terner-Rosenthal, Robin Howard, Renee Shiota et al.
2026-11-12
DOI: 10.1007/s12325-026-03844-5
Epidemiology, Complications, and Management of Complications of Achondroplasia: A Systematic Literature Review and Meta-analysis
Alden R. Smith, Aimee D. Shu, Lærke Clement Freiberg et al.
2026-11-12
DOI: 10.1007/s12325-026-03838-3
Measuring the Effect of Amphetamine Extended-Release (DYANAVEL® XR) on Driving Performance in Young Adult Drivers with ADHD Using a Sophisticated Driving Simulation
Craig Surman, Bruce Mehler, Ronna Fried et al.
2026-11-10
DOI: 10.1007/s12325-026-03843-6
Efficacy and Safety of Dapagliflozin, Glimepiride, and Metformin Fixed-Dose Combination Tablet in Type 2 Diabetes: A Phase III Trial
Prakash Kurmi, Manish Kumar Singh, Vishal Gupta et al.
2026-11-2
DOI: 10.1007/s12325-026-03791-1
Teclistamab Plus Daratumumab Versus Standard Daratumumab-Based Proteasome Inhibitor Combinations for Relapsed/Refractory Multiple Myeloma: An Inverse Probability of Treatment Weighting Analysis
Larry D. Anderson, Sandhya Nair, Mi Jun Keng et al.
2026-11-2
DOI: 10.1007/s12325-026-03832-9
Correction: Pharmacokinetics, Safety, and Immunogenicity of DMB-3115, a Ustekinumab Biosimilar for Immune-Mediated Diseases, in Healthy Japanese Male Participants: A Randomized, Double-Blind, Single-Dose Study
Hironori Konishi, Yuji Kumagai, Takeyuki Shindo et al.
2026-10-27
DOI: 10.1007/s12325-026-03822-x
Sirolimus and Immunoglobulin Replacement Therapy in Patients with Activated Phosphoinositide 3-Kinase Delta Syndrome (APDS): A Systematic Literature Review
Nicholas L. Hartog, Konrad Pisarczyk, Mike Samad et al.
2026-10-26
DOI: 10.1007/s12325-026-03833-8
Skeletal Muscle in Vulnerable Populations Receiving Cardiorenal-Metabolic Therapies: SGLT2 Inhibitors, Incretin-Based Therapies, and the Challenge of Precision Medicine
Theocharis Koufakis, Anastasios Tentolouris, Eleni Manthou et al.
2026-10-26
DOI: 10.1007/s12325-026-03829-4
Characteristics and Treatment Utilisation Patterns of Individuals Using Tirzepatide for Type 2 Diabetes in Germany
Martin Füchtenbusch, Marius Kraus, Elke Heitmann et al.
2026-10-26
DOI: 10.1007/s12325-026-03767-1
Islet Function Phenotyping-Based Heterogeneity in New-Onset Type 2 Diabetes: Clinical Importance and Baseline Metabolic Phenotype in a Large-Sample Cohort
Jun Guo, Manman Song, Yu Zhou et al.
2026-10-26
DOI: 10.1007/s12325-026-03821-y
Articles retrieved from Crossref.
Green Journals | https://www.green-journals.com | info@green-journals.com
Printed: November 12, 2026 09:33